Skip to main content
Premium Trial:

Request an Annual Quote

NeoClone Nabs $750K SBIR Grant to Continue Developing Ovarian Cancer Antibody Array

NEW YORK (GenomeWeb News) — NeoClone Biotechnology has received a $750,000 Phase II Small Business Innovation Research grant from the National Institutes of Health to help it continue developing an antibody microarray for ovarian cancer, the company said this week.
The funding, administered through the National Cancer Institute, will pay for continued research and new equipment and staff for its Madison, Wis., labs.
NeoClone said the antibody array will use its proprietary method for generating monoclonal antibodies to certain ovarian cancer-related targets.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.